Valsartan Lawsuit Settlement Nears for Hetero, But Fight
WEBJun 18, 2024 · Lawyers are nearing a settlement agreement for those who sued Hetero, a manufacturer of valsartan, a generic blood pressure medication tainted with carcinogens.
FDA approves a new generic valsartan | FDA - U.S. Food and Drug ...
WEBToday, the U.S. Food and Drug Administration approved a new generic of Diovan (valsartan). Valsartan is an angiotensin II receptor blocker (ARB) that treats high blood pressure and heart failure.
FDA Statement on FDA’s ongoing investigation into valsartan …
WEBValsartan is an angiotensin II receptor blocker (ARB) that treats high blood pressure and heart failure. The FDA currently has a major operation underway to investigate and address this troubling...
FDA provides update on its ongoing investigation into valsartan ...
WEBThe U.S. Food and Drug Administration is updating the public on the agency’s ongoing investigation surrounding the recent voluntary recall of several drug products containing the active...
New Details Revealed About Blood Pressure Medicine Recalled for …
WEBJun 19, 2023 · The U.S. Food and Drug Administration is being accused of not doing enough to ensure carcinogens aren’t contaminating drugs during the manufacturing process. Valsartan was recalled worldwide in 2018 following studies that found the blood pressure medication contained unacceptable amounts …
After multiple recalls, FDA approves new generic for valsartan
WEBMar 13, 2019 · The U.S. Food and Drug Administration has approved a new generic of the blood pressure medication valsartan to help alleviate a recent shortage due to multiple safety recalls.
Valsartan Recall | FDA Recalls Contaminated Drug Linked to Cancer
WEBSep 1, 2020 · The valsartan recall was prompted by the discovery of a cancer-causing substance in the medications. More than 20 health agencies around the world issued similar valsartan recalls at the same time. The FDA launched an investigation to determine the cause and impact of the valsartan contamination.
Valsartan recall: 4 things patients should know | CNN
WEBJul 19, 2018 · Several common drugs that contain valsartan, used to treat high blood pressure and heart failure, have been recalled in the United States due to an “impurity” in the drug that poses a potential...
Valsartan Recall | Why Is the FDA Recalling Valsartan? - Drugwatch
WEBJan 24, 2024 · On July 13, 2018, the FDA announced a voluntary recall of some valsartan products because of contamination with NDMA, a potentially cancer-causing chemical. Other drugs affected by the valsartan recall include losartan and irbesartan.
Valsartan Lawsuit News and Updates - TheLawFirm.com
WEBValsartan Lawsuit News: As Valsartan MDL Passes 260 Cases, Court Postpones In-Person Conference; Future Conferences To Proceed As Scheduled For Now. March 26, 2020 Author: Daniel Gala